At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,869 enrolled
Drug / intervention
Prevena Incision Management System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Negative Pressure Wound Therapy for Prevention of Wound Infection After Heart Surgery
In Brief
A clinical study evaluating Prevena Incision Management System and Conventional sterile dry wound dressing for Surgical Wound Infection. Completed, enrolled 1,869 participants across 1 site.
Detailed Summary
This prospective study evaluates the role of negative pressure wound therapy or wound VAC as a dressing over the incision to prevent poststernotomy wound infection in high risk patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSurgical Wound Infection
CountriesUnited States
CollaboratorsKCI USA, Inc
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedDec 2013
Primary CompletionOct 2018
TodayJul 2026
First PostedDec 24, 2013
Enrollment StartOct 1, 2013
Primary CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 12.5 years ago
Interventions
Prevena Incision Management Systemdevice
negative pressure therapy that will be applied instead of the regular dressing immediately postoperatively in high risk patients and kept for 6-7 days
Conventional sterile dry wound dressingother
regular dressing that is applied immediately postoperatively for high risk patients in the operating room after sternotomy